Earnings
PLXS
206.22
+2.56%
5.15
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2025
4.03B
4.03B
--
3.63B
406.51M
204.14M
199.46M
--
--
--
4.68M
--
202.37M
-7.68M
--
-6.67M
188.02M
15.13M
172.88M
--
--
--
172.88M
--
172.88M
--
172.88M
172.88M
--
172.88M
27.62M
6.26
6.26
--
6.45
FY 2024
3.96B
3.96B
--
3.58B
378.53M
210.80M
190.54M
--
--
--
20.26M
--
167.73M
-25.02M
--
-13.18M
129.53M
17.72M
111.81M
--
--
--
111.81M
--
111.81M
--
111.81M
111.81M
--
111.81M
27.91M
4.01
4.01
--
4.81
FY 2023
4.21B
4.21B
--
3.82B
394.55M
198.73M
175.64M
--
--
--
23.09M
--
195.82M
-30.20M
--
-4.60M
161.01M
21.92M
139.09M
--
--
--
139.09M
--
139.09M
--
139.09M
139.09M
--
139.09M
28.11M
4.95
4.95
--
5.84
FY 2022
3.81B
3.81B
--
3.46B
347.23M
169.04M
167.02M
--
--
--
2.02M
--
178.19M
-15.25M
--
-4.63M
158.30M
20.06M
138.24M
--
--
--
138.24M
--
138.24M
--
138.24M
138.24M
--
138.24M
28.44M
4.86
4.86
--
4.94
FY 2021
3.37B
3.37B
--
3.05B
323.30M
147.03M
143.76M
--
--
--
3.27M
--
176.27M
-12.88M
--
-2.98M
160.41M
21.50M
138.91M
--
--
--
138.91M
--
138.91M
--
138.91M
138.91M
--
138.91M
29.17M
4.76
4.76
--
4.86

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.